PER 5.26% 8.0¢ percheron therapeutics limited

EQUITY RESEARCH REPORT - WILSON dated 18 Jan 2022, page-112

  1. 149 Posts.
    lightbulb Created with Sketch. 120
    I have to say that holding this stock has been exciting but the quietness on the shortfall of capital raised is such a big question mark for this stock.

    l know many have got lots of issues with the last raising but I think the capital raising and the intention is probably not the worst part. In fact I thought the design and the options were a sort of compromise (albeit not a great one).

    What is quite hard to swallow however is the lack of communication after the shortfall. Integrity and transparency of management is what I'm looking for. AND they should have had a backup plan. Had hoped this issue would be addressed in the Quarterly.

    Please do let me know if I've missed anything.

    Last edited by CrispyPork777: 01/02/22
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.004(5.26%)
Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.7¢ $35.48K 451.2K

Buyers (Bids)

No. Vol. Price($)
1 12500 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 198147 2
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.